‘Significant’ Technion discovery in basic understanding of cancer

April 12, 2015 19:33

Researchers at the Technion-Israel Institue of Technology’s Rappaport Faculty of Medicine who have discovered two cancer-suppressing proteins, could hold one key to control cancer cell growth and development. Their “significant discovery” was conducted in the lab of 2004 Nobel Prize co-winner Prof. Aaron Ciechanover and just published in the most-recent edition of the prestigious journal Cell.

Ciechanover, who is also the president of the Israel Cancer Society, stressed on Sunday that “many more years are required to establish the research and gain a solid understanding of the mechanisms behind the suppression of the tumors. The development of a drug based on this discovery is a possibility, although not a certainty, and the road to such a drug is long and far from simple.”

The team was led by research associate Dr. Yelena Kravtsova-Ivantsiv and , included additional research students and colleagues, as well as physicians from the Rambam, Carmel and Hadassah University Medical Centers who are studying tumors and their treatment.

Related Content

Breaking news
May 23, 2018
Top Greek court grants Turkish soldier asylum, rejects government appeal